Heart in a Box
Since the first heart transplant in 1967, there has been a shortage of donor hearts available for people who need them. New ways of retrieving donor hearts—and transporting them—could change that. Sentara Healthcare is at the forefront of research that could expand the pool of donor hearts available for transplantation.
Sentara Chosen for Clinical Trial on New Method of Heart Transplant
Researchers are studying a procedure called donation after circulatory death (DCD), along with a device that keeps hearts warm and beating during transport. Sentara has been accepted as one of up to 25 centers nationwide in this new clinical research trial. The clinical trial will evaluate the safety and effectiveness of the portable organ care system (OCS™) heart for resuscitation, preservation and assessment of hearts from donors after circulatory death (Heart DCD Continued Access Protocol (OCS DCD Heart CAP) Trial.
Learn more about the trial and the technology at the following links:
- Donors After Circulatory Death Heart Trial at the U.S. National Library of Medicine, part of the National Institutes of Health
- OCS™ Heart – the only device currently under FDA review for utilized and unutilized donor hearts.
For more information about clinical trials at Sentara, please email research@sentara.com or call 1-833-866-7766.